Home › Topics › Other FDA topics

FDA comment periods: Other FDA topics

20 open comment periods and 2 upcoming effective dates tagged Other FDA topics. Subscribe (iCal).

Open for comment

Closes	Document
closes today Oct 17, 2026	Reauthorization of the Generic Drug User Fee Amendments; Public Meeting; Request for Comments Notice · published Aug 11, 2026 · FDA-2025-N-0873 Other FDA topics
closes in 2 days Oct 19, 2026	Determining Whether To Submit an ANDA or a 505(b)(2) Application; Draft Guidance for Industry; Availability Notice · published Aug 18, 2026 · FDA-2017-D-5974 Other FDA topics
closes in 4 days Oct 21, 2026	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Orphan Drugs Notice · published Sep 21, 2026 · FDA-2026-N-3400 Other FDA topics
closes in 10 days Oct 27, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Focus Groups and Interviews as Used by the Food and Drug Administration Notice · published Aug 28, 2026 · FDA-2026-N-8087 Other FDA topics
closes in 10 days Oct 27, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Qualitative Feedback on Agency Service Delivery Notice · published Aug 28, 2026 · FDA-2026-N-8898 Other FDA topics
closes in 16 days Nov 2, 2026	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Voluntary Improvement Program Notice · published Oct 1, 2026 · FDA-2026-N-6876 Other FDA topics
closes in 17 days Nov 3, 2026	Advancing Development of Botanical Drug Products; Request for Information Notice · published Sep 4, 2026 · FDA-2026-N-9550 Other FDA topics
closes in 17 days Nov 3, 2026	Establishment of a Quantitative Medicine Innovation Network: Scope, Feasibility, and Opportunities; Request for Information Notice · published Aug 5, 2026 · FDA-2026-N-7605 Other FDA topics
closes in 23 days Nov 9, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Pregnancy Exposure Registry Enrollment Project: A Survey of Health Care Providers To Advance Pregnancy Safety Data Collection and Improve Health Communications Notice · published Sep 9, 2026 · FDA-2026-N-8361 Other FDA topics
closes in 23 days Nov 9, 2026	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Expanded Access to Investigational Drugs for Treatment Use Notice · published Oct 9, 2026 · FDA-2026-N-7426 Other FDA topics
closes in 27 days Nov 13, 2026	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Requirements for Cosmetic Products Notice · published Oct 14, 2026 · FDA-2026-N-6739 Other FDA topics
closes in 31 days Nov 17, 2026	Target Animal Safety Evaluation for Veterinary Monoclonal Antibody Products; Draft Guidance for Industry; Availability Notice · published Sep 18, 2026 · FDA-2026-D-7233 Other FDA topics
closes in 34 days Nov 20, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; State Petitions for Exemption From Preemption Notice · published Sep 21, 2026 · FDA-2026-N-10430 Other FDA topics
closes in 34 days Nov 20, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Temporary Marketing Permit Applications Notice · published Sep 21, 2026 · FDA-2026-N-10363 Other FDA topics
closes in 51 days Dec 7, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Channels of Trade Policy for Commodities With Residues of Pesticide Chemicals, for Which Tolerances Have Been Revoked, Suspended, or Modified by the Environmental Protection Agency Pursuant to Dietary Risk Considerations Notice · published Oct 8, 2026 · FDA-2026-N-10605 Other FDA topics
closes in 52 days Dec 8, 2026	Determination of Regulatory Review Period for Purposes of Patent Extension; MONOFERRIC Notice · published Oct 9, 2026 · FDA-2020-E-1882, FDA-2020-E-1892 Other FDA topics
closes in 72 days Dec 28, 2026	Determination of Regulatory Review Period for Purposes of Patent Extension; VYALEV Notice · published Jun 29, 2026 · FDA-2025-E-0162, FDA-2025-E-0163, FDA-2025-E-0164 Other FDA topics
closes in 114 days Feb 8, 2027	Determination of Regulatory Review Period for Purposes of Patent Extension; BRINSUPRI Notice · published Aug 10, 2026 · FDA-2025-E-5206 Other FDA topics
closes in 114 days Feb 8, 2027	Determination of Regulatory Review Period for Purposes of Patent Extension; DAYVIGO Notice · published Aug 10, 2026 · FDA-2025-E-0707 Other FDA topics
closes in 142 days Mar 8, 2027	Determination of Regulatory Review Period for Purposes of Patent Extension; ANZUPGO Notice · published Sep 9, 2026 · FDA-2025-E-3939 Other FDA topics

Upcoming effective dates

Effective	Document
effective in 348 days Sep 30, 2027	Animal Drug User Fee Rates and Payment Procedures for Fiscal Year 2027 Notice · published Jul 30, 2026 · FDA-2026-N-7558 Other FDA topics
effective in 2333 days Mar 7, 2033	Revising the National Drug Code Format and Drug Label Barcode Requirements Rule · published Mar 5, 2026 · FDA-2021-N-1351 Other FDA topics

Recently closed

Closes	Document
closed 1 day ago Oct 16, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries Notice · published Aug 17, 2026 · FDA-2026-N-8328 Other FDA topics
closed 3 days ago Oct 14, 2026	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Customer/Partner Customer Service Satisfaction Surveys Notice · published Sep 14, 2026 · FDA-2026-N-2740 Other FDA topics
closed 15 days ago Oct 2, 2026	Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs; Revised Draft Guidance for Industry; Availability Notice · published Aug 3, 2026 · FDA-2018-D-3546 Other FDA topics
closed 16 days ago Oct 1, 2026	Animal Generic Drug User Fee Program Rates and Payment Procedures for Fiscal Year 2027 Notice · published Jul 30, 2026 · FDA-2026-N-7498 Other FDA topics
closed 16 days ago Oct 1, 2026	Animal Drug User Fee Rates and Payment Procedures for Fiscal Year 2027 Notice · published Jul 30, 2026 · FDA-2026-N-7558 Other FDA topics
closed 19 days ago Sep 28, 2026	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Reporting Associated With Animal Drug and Animal Generic Drug User Fees Notice · published Aug 28, 2026 · FDA-2026-N-2365 Other FDA topics
closed 19 days ago Sep 28, 2026	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Importation of Prescription Drugs Notice · published Aug 28, 2026 · FDA-2026-N-3240 Other FDA topics
closed 19 days ago Sep 28, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Expanded Access to Investigational Drugs for Treatment Use Notice · published Jul 28, 2026 · FDA-2026-N-7426 Other FDA topics
closed 32 days ago Sep 15, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Requirements for Cosmetic Products Notice · published Jul 17, 2026 · FDA-2026-N-6739 Other FDA topics
closed 32 days ago Sep 15, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Accreditation Scheme for Conformity Assessment Program Notice · published Jul 17, 2026 · FDA-2026-N-7130 Other FDA topics
closed 43 days ago Sep 4, 2026	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Food and Drug Administration Advisory Committees Notice · published Aug 5, 2026 · FDA-2026-N-2364 Other FDA topics
closed 44 days ago Sep 3, 2026	International Drug Scheduling; Single Convention on Narcotic Drugs; Convention on Psychotropic Substances; Clobromazolam (Phenazolam); Cychlorphine (N-Propionitrile Chlorphine); Desalkylgidazepam (Bromonordiazepam); Ethylbromazolam; Etomethazene (5-Methyl Etodesnitazene); Spirochlorphine (R6980); Etomidate; Medetomidine; Request for Comments Notice · published Aug 26, 2026 · FDA-2026-N-9208 Other FDA topics
closed 52 days ago Aug 26, 2026	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Radioactive Drug Research Committees Notice · published Jul 27, 2026 · FDA-2026-N-3099 Other FDA topics
closed 53 days ago Aug 25, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Time and Extent Applications for Nonprescription Drug Products Notice · published Jun 26, 2026 · FDA-2026-N-5827, FDA_FRDOC_0001 Other FDA topics
closed 54 days ago Aug 24, 2026	Master Protocols for Drug and Biological Product Development; Draft Guidance for Industry; Availability Notice · published Jun 24, 2026 · FDA-2023-D-5259 Other FDA topics
closed 61 days ago Aug 17, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Extralabel Drug Use in Animals Notice · published Jun 18, 2026 · FDA-2026-N-5829 Other FDA topics
closed 64 days ago Aug 14, 2026	Forms FDA 3542a and FDA 3542: Questions and Answers; Draft Guidance for Industry; Availability Notice · published Jun 15, 2026 · FDA-2026-D-2698 Other FDA topics
closed 73 days ago Aug 5, 2026	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Administrative Practices and Procedures; Formal Hearings Notice · published Jul 6, 2026 · FDA-2026-N-2431 Other FDA topics
closed 78 days ago Jul 31, 2026	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medication Guides for Prescription Drug Products Notice · published Jul 1, 2026 · FDA-2025-N-6869 Other FDA topics
closed 80 days ago Jul 29, 2026	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; New Animal Drugs for Minor Use and Minor Species Notice · published Jun 29, 2026 · FDA-2026-N-1305 Other FDA topics
closed 86 days ago Jul 23, 2026	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Certification of Identity, Form FDA 3975 Notice · published Jun 23, 2026 · FDA-2025-N-1732 Other FDA topics
closed 96 days ago Jul 13, 2026	Drug Repurposing for Unmet Medical Needs; Request for Information; Extension of Comment Period Notice · published Jun 11, 2026 · FDA-2026-N-4492 Other FDA topics
closed 96 days ago Jul 13, 2026	Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information Notice · published May 13, 2026 · FDA-2026-N-0005 Other FDA topics
closed 96 days ago Jul 13, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting Notice · published May 13, 2026 · FDA-2026-N-3098 Other FDA topics
closed 99 days ago Jul 10, 2026	Fiscal Year 2026 Generic Drug Science and Research Initiatives Workshop; Public Workshop; Request for Comments Notice · published Feb 27, 2026 · FDA-2023-N-0119 Other FDA topics
closed 109 days ago Jun 30, 2026	Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments Notice · published May 1, 2026 · FDA-2026-N-3499 Other FDA topics
closed 109 days ago Jun 30, 2026	Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comments Notice · published May 1, 2026 · FDA-2026-N-3947 Other FDA topics
closed 110 days ago Jun 29, 2026	Determination of Regulatory Review Period for Purposes of Patent Extension; ZELSUVMI Notice · published Dec 29, 2025 · FDA-2024-E-1293 Other FDA topics
closed 110 days ago Jun 29, 2026	ChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a Hearing Notice · published Apr 30, 2026 · FDA-2026-N-1321 Other FDA topics
closed 110 days ago Jun 29, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Good Laboratory Practice Requirements for Nonclinical Laboratory Studies Notice · published Apr 30, 2026 · FDA-2026-N-3532 Other FDA topics
closed 117 days ago Jun 22, 2026	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Patent Term Restoration; Due Diligence Petitions; Filing, Format, and Content of Petitions Notice · published May 21, 2026 · FDA-2026-N-0497 Other FDA topics
closed 117 days ago Jun 22, 2026	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Adverse Experience/Events With Approved New Animal Drugs Notice · published May 21, 2026 · FDA-2026-N-1303 Other FDA topics
closed 123 days ago Jun 16, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Radioactive Drug Research Committees Notice · published Apr 17, 2026 · FDA-2026-N-3099 Other FDA topics
closed 124 days ago Jun 15, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Orphan Drugs Notice · published Apr 16, 2026 · FDA-2026-N-3400 Other FDA topics
closed 124 days ago Jun 15, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Importation of Prescription Drugs Notice · published Apr 16, 2026 · FDA-2026-N-3240 Other FDA topics
closed 127 days ago Jun 12, 2026	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3 Notice · published May 13, 2026 · FDA-2025-N-1600 Other FDA topics
closed 128 days ago Jun 11, 2026	Drug Repurposing for Unmet Medical Needs; Request for Information Notice · published May 12, 2026 · FDA-2026-N-4492 Other FDA topics
closed 131 days ago Jun 8, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Administrative Practices and Procedures; Formal Hearings Notice · published Apr 7, 2026 · FDA-2026-N-2431 Other FDA topics
closed 137 days ago Jun 2, 2026	Determination of Regulatory Review Period for Purposes of Patent Extension; INJECTAFER Notice · published Apr 3, 2026 · FDA-2014-E-2328 Other FDA topics
closed 137 days ago Jun 2, 2026	Agency Information Collection Activities; Proposed Collection; Comment Request; Customer/Partner Customer Service Satisfaction Surveys Notice · published Apr 3, 2026 · FDA-2026-N-2740 Other FDA topics

Topics are assigned automatically from 21 CFR part numbers and keywords in the title and abstract (see method), so a document can carry several topics and tagging can miss. Use the search on the main list to double-check.